Management of cardiac toxicity in patients receiving vascular endothelial growth factor signaling pathway inhibitors-Reference-Cited by-同舟云学术

Management of cardiac toxicity in patients receiving vascular endothelial growth factor signaling pathway inhibitors

Published:2012-02 Issue:2 Volume:163 Page:156-163
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Steingart Richard M.,Bakris George L.,Chen Helen X.,Chen Ming-Hui,Force Thomas,Ivy S. Percy,Leier Carl V.,Liu Glenn,Lenihan Daniel,Lindenfeld JoAnn,Maitland Michael L.,Remick Scot C.,Tang W.H. Wilson

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference28 articles.

1. Initial assessment, surveillance and management of blood pressure in patients receiving vascular endothelial growth factor pathway inhibitors;Maitland;J Natl Cancer Inst,2010

2. Cardiotoxicity associated with the cancer therapeutic agent sunitinib malate;Telli;Ann Oncol,2008

3. Targeted therapies for metastatic renal cell carcinoma: an overview of toxicity and dosing strategies;Hutson;The Oncologist,2008

4. Molecular mechanism of cardiotoxicity of tyrosine kinase inhibition;Force;Nat Rev Cancer,2007

5. Sutent (sunitinib malate) capsules [package insert],2008

Cited by 104 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of new and emerging cancer drugs: what the cardiologist needs to know;European Heart Journal;2024-04-09

2. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension;Journal of Hypertension;2023-09-26

3. Cardiovascular Toxicity Induced by Vascular Endothelial Growth Factor Inhibitors;Life;2023-01-29

4. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS);European Heart Journal;2022-08-26

5. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS);European Heart Journal - Cardiovascular Imaging;2022-08-26